MELISSA SPENCER-WINKER: Open Payments
NPI 1003885385 · DEPEW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 75 payments from 18 companies in 2025. Trend: 2023 $166 · 2024 $495 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $308 |
| GENZYME CORPORATION | 6 | $232 |
| UCB, Inc. | 10 | $192 |
| Merck Sharp & Dohme LLC | 8 | $164 |
| Janssen Biotech, Inc. | 5 | $149 |
| Lilly USA, LLC | 1 | $125 |
| PFIZER INC. | 4 | $113 |
| Incyte Corporation | 5 | $106 |
| Galderma Laboratories, L.P. | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
Products named: DUPIXENT, Bimzelx, RINVOQ, KEYTRUDA, SKYRIZI, EBGLYSS, CIBINQO, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
